The Glycobiology Laboratory was established in July of 2000. We are interested in understanding the biosynthesis of heparan sulfate polysaccharides and developing an enzymatic approach to synthesize polysaccharide-based therapeutic agents. This laboratory is currently supported by grants from the National Institutes of Health and the American Heart Association.

Research goals

Develop a novel method to synthesize anticoagulant Heparin drug and antiviral drugs by targeting the biosynthesis of Heparan Sulfate.

Dr. Liu on CNN

Dr. Liu was interviewed on CNN in 2008 for a story about contaminated heparin in the U.S.